Data for 10,000 AML cells were then objectively quantified using the inbuilt AMNIS® analysis (IDEAS®) software and revealed a significantly higher co-localization score (p = 0.0004) between CD162 and E-selectin compared to CD44 and E-selectin (Figure 1B). The gene discussed is SELE; the disease is acute myeloid leukemia.